Calendar of Events

The Digital Therapeutics Alliance hosts a variety of events for members and non-members to engage throughout the year. These events cover an array of topics including regulatory and reimbursement updates, industry best practices, current DTA projects and initiatives, and more.

Upcoming Events

September

September 19 at 3:00PM KST | Current Status of DTx Reimbursement and Adoption in Korea: Opportunities for Local and International Companies | Free

Korea has emerged as a significant market for DTx in the APAC region, with unique challenges and opportunities related to reimbursement and adoption. This webinar aims to explore the current landscape in Korea and provide valuable insights for both local and international companies seeking to enter or expand in
this market.

Learn More and Register

_______________________________________________________________________________________________________________

September 25 at 11:00AM ET | Prescription DTx Integration into Healthcare System Workflows | $25 for Non-Members

The integration of digital therapeutic products into existing workflows is critical for provider and payor adoption at scale. The Digital Therapeutics Alliance is working with important stakeholder groups to uncover the intricacies and requirements by product manufacturers, health plans, PBMs, provider systems, pharmacies, distributors, and others to ultimately provide patients access to these innovative treatments.

Join this panel discussion to learn about the entire health system workflow with differing payment and patient access pathways and how they impact workflows for other stakeholders. Attendees will learn how to work with each stakeholder to integrate DTx products in a standardized and recognized practice.

Learn More and Register

_______________________________________________________________________________________________________________

September 26 at 11:00AM ET | Navigating Workflow and Distribution for Non-Prescription DTx | $25 for Non-Members

Join us for an insightful webinar on the workflow and distribution pathways for non-prescription digital therapeutics (DTx). This session will explore how theseinnovative tools can be effectively integrated into employer benefit programs and health plan platforms, providing personalized health interventions without the need for a prescription.

Learn More and Register

_______________________________________________________________________________________________________________

September 30 at 11:00AM ET | Q3 DTA Town Hall | Member-Only Event

Join DTA members and staff as we discuss priorities to address in 2025. This conversation is part of DTA’s annual strategic planning and will include:

  • A report from the 2024 DTA member survey
  • A report from the 2024 DTA advisory board survey
  • Discussion around 2025 priorities
  • Board of Directors Elections
  • Next steps in strategic planning

Register now to give your input on the 2025 strategic priorities!

 

Contact DTA to Learn More

_______________________________________________________________________________________________________________

October

October 15 at 11:00AM ET | DTx Demo Day: National Physical Therapy Month | Free

In recognition of National Physical Therapy Month, the Digital Therapeutics Alliance is hosting a DTx Demo Day, focusing on innovative digital solutions in the physical therapy and musculoskeletal (MSK) rehabilitation space. Join us as we explore the future of physical therapy and rehabilitation through the lens of digital therapeutics.

Learn More and Register

_______________________________________________________________________________________________________________

October 17 at 12:00PM ET | Product Launch Meet-Up: Unbranded Awareness Campaigns in DTx | Free

In 2022, the Digital Therapeutics Alliance published the DTx Commercial Launch Playbook in partnership with ClearView Healthcare Partners. The playbook is designed to provide a standard set of considerations to help execute a successful product launch and understand the resources necessary to launch a DTx product. During our monthly Product Launch Meetup with ClearView we will be covering a different “tab” from the launch playbook. In October, we will be diving into the activities in the medical affairs tab.

Disease state education is crucial for digital therapeutics (DTx) manufacturers as it enhances awareness and understanding of specific health conditions, thereby facilitating informed decision-making among healthcare providers, patients, and payors. By providing comprehensive, unbranded education, DTx manufacturers can build trust and credibility, ultimately supporting the adoption and integration of their innovative solutions into mainstream healthcare.

Learn More and Register

_______________________________________________________________________________________________________________

_______________________________________________________________________________________________________________

November

_______________________________________________________________________________________________________________

December

Copyright © 2024 Digital Therapeutics Alliance™